| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |